SCHEMBL7230127

SCHEMBL7230127

CCN(CC)c1ccc2c(=O)c3ccc(N(CC)CC)cc3oc2c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 13/20 0.67
▸ GLA P06280 7/20 0.67
▸ ATM Q13315 7/20 0.67
▸ L3MBTL1 Q9Y468 6/20 0.67
▸ HPGD P15428 6/20 0.67
▸ CASP1 P29466 5/20 0.67
▸ CASP7 P55210 5/20 0.67
▸ HSD17B10 Q99714 5/20 0.67
▸ CYP3A4 P08684 3/20 0.67
▸ IGLV6-57 P01721 3/20 0.67
▸ MAPK1 P28482 2/20 0.67
▸ HIF1A Q16665 2/20 0.67
▸ KDM4E B2RXH2 10/20 0.65
▸ MAPT P10636 8/20 0.65
▸ MEN1 O00255 8/20 0.65
▸ KMT2A Q03164 8/20 0.65
▸ TDP1 Q9NUW8 4/20 0.65
▸ CYP1A2 P05177 3/20 0.65
▸ CYP2C19 P33261 3/20 0.65
▸ CYP2C9 P11712 2/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29582092 1.00 ALDH1A1 (0.67) ALDH1A1GLAATML3MBTL1HPGD
SCHEMBL30025646 0.86 ALDH1A1 (0.59) ALDH1A1GLAATML3MBTL1HPGD
SCHEMBL10098672 0.86 ALDH1A1 (0.59) ALDH1A1GLAATML3MBTL1HPGD
SCHEMBL11296750 0.81 ALDH1A1 (0.78) ALDH1A1GLAATML3MBTL1HPGD
SCHEMBL384286 0.80 ALDH1A1 (1.00) ALDH1A1GLAATML3MBTL1HPGD
SCHEMBL29362472 0.80 ALDH1A1 (1.00) ALDH1A1GLAATML3MBTL1HPGD
SCHEMBL67108 0.80 ALDH1A1 (1.00) ALDH1A1GLAATML3MBTL1HPGD
SCHEMBL6690441 0.80 ALDH1A1 (0.73) ALDH1A1GLAATML3MBTL1HPGD
SCHEMBL840516 0.79 KDM4E (0.48) ALDH1A1GLAATML3MBTL1HPGD
SCHEMBL30352933 0.79 KDM4E (0.48) ALDH1A1GLAATML3MBTL1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6613797-B2 New xanthone derivatives useful for treating protozoan diseases INTERLAB, INC. 2003-09-02 — — US claimed
US-20020055644-A1 Xanthone analogs for treating infectious diseases and complexation of heme and porphyrins INTERLAB, INC. 2002-05-09 — — US claimed
WO-2001041773-A1 XANTHONE ANALOGS FOR TREATING INFECTIOUS DISEASES AND COMPLEXATION OF HEME AND PORPHYRINS INTERLAB, INC. (US) 2001-06-14 — — WO claimed
US-20180052105-A1 SULFANE SULFUR-SELECTIVE FLUORESCENT PROBE THE UNIVERSITY OF TOKYO (JP) 2018-02-22 — — US disclosed
EP-1619023-B1 Image forming material FUJIFILM CORP (JP) 2008-06-11 — — EP disclosed
US-6613797-B2 New xanthone derivatives useful for treating protozoan diseases INTERLAB, INC. 2003-09-02 — — US disclosed
US-20020055644-A1 Xanthone analogs for treating infectious diseases and complexation of heme and porphyrins INTERLAB, INC. 2002-05-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020055644-A1 Xanthone analogs for treating infectious diseases and complexation of heme and porphyrins XPA, XDH, HMOX1 ALDH1A1 4117/4885GLA 2030/4885ATM 1746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback